A phase Ib trial of Bcl-2 inhibitor obatoclax in combination with carboplatin and etoposide for previously untreated patients with extensive-stage small cell lung cancer (ES-SCLC)Alberto Chiappori, M. S. Berger, M. Moezi et al.|Journal of Clinical Oncology|2009Cited by 11